Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

United States Stem Cell Cord Blood Sales Market Report 2021

  • QYR629491
  • 123 Pages
  • July 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
This report studies sales (consumption) of Stem Cell Cord Blood in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering

Caladrius Biosciences?

Celgene?

Mesoblast?

Pluristem Therapeutics

Athersys

CHA Bio & Diostech?

Cytori Therapeutics

Nuo Therapeutics?

Ocata Therapeutics?

Opexa Therapeutics?

Osiris Therapeutics?

Teva Pharmaceuticals?

United Therapeutics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

POC

Tissue diagnostic

Clinical microbiology

Immunodiagnostics

Molecular diagnostics

Hematology

Split by applications, this report focuses on sales, market share and growth rate of Stem Cell Cord Blood in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Stem Cell Cord Blood Sales Market Report 2021

1 Stem Cell Cord Blood Overview

1.1 Product Overview and Scope of Stem Cell Cord Blood

1.2 Classification of Stem Cell Cord Blood

1.2.1 POC

1.2.2 Tissue diagnostic

1.2.3 Clinical microbiology

1.2.4 Immunodiagnostics

1.2.5 Molecular diagnostics

1.2.6 Hematology

1.3 Applications of Stem Cell Cord Blood

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size (Value and Volume) of Stem Cell Cord Blood (2011-2021)

1.4.1 USA Stem Cell Cord Blood Sales, Revenue and Price (2011-2021)

1.4.2 USA Stem Cell Cord Blood Sales and Growth Rate (2011-2021)

1.4.3 USA Stem Cell Cord Blood Revenue and Growth Rate (2011-2021)

2 USA Stem Cell Cord Blood Competition by Manufacturers

2.1 USA Stem Cell Cord Blood Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Stem Cell Cord Blood Revenue and Share by Manufactures (2015 and 2016)

3 USA Stem Cell Cord Blood (Volume and Value) by Type

3.1 USA Stem Cell Cord Blood Sales and Market Share by Type (2011-2021)

3.2 USA Stem Cell Cord Blood Revenue and Market Share by Type (2011-2021)

4 USA Stem Cell Cord Blood (Volume) by Application

5 USA Stem Cell Cord Blood Manufacturers Analysis

5.1 Caladrius Biosciences?

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Stem Cell Cord Blood Product Type and Technology

5.1.2.1 POC

5.1.2.2 Tissue diagnostic

5.1.3 Stem Cell Cord Blood Sales, Revenue, Price of Caladrius Biosciences? (2015 and 2016)

5.2 Celgene?

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharma & Healthcare Product Type and Technology

5.2.2.1 POC

5.2.2.2 Tissue diagnostic

5.2.3 Pharma & Healthcare Sales, Revenue, Price of Celgene? (2015 and 2016)

5.3 Mesoblast?

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Mesoblast? Product Type and Technology

5.3.2.1 POC

5.3.2.2 Tissue diagnostic

5.3.3 Mesoblast? Sales, Revenue, Price of Mesoblast? (2015 and 2016)

5.4 Pluristem Therapeutics

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Ocata Therapeutics? Product Type and Technology

5.4.2.1 POC

5.4.2.2 Tissue diagnostic

5.4.3 Pluristem Therapeutics Sales, Revenue, Price of Pluristem Therapeutics (2015 and 2016)

5.5 Athersys

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Athersys Product Type and Technology

5.5.2.1 POC

5.5.2.2 Tissue diagnostic

5.5.3 Athersys Sales, Revenue, Price of Athersys (2015 and 2016)

5.6 CHA Bio & Diostech?

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 CHA Bio & Diostech? Product Type and Technology

5.6.2.1 POC

5.6.2.2 Tissue diagnostic

5.6.3 CHA Bio & Diostech? Sales, Revenue, Price of CHA Bio & Diostech? (2015 and 2016)

5.7 Cytori Therapeutics

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Cytori Therapeutics Product Type and Technology

5.7.2.1 POC

5.7.2.2 Tissue diagnostic

5.7.3 Cytori Therapeutics Sales, Revenue, Price of Cytori Therapeutics (2015 and 2016)

5.8 Nuo Therapeutics?

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Nuo Therapeutics? Product Type and Technology

5.8.2.1 POC

5.8.2.2 Tissue diagnostic

5.8.3 Nuo Therapeutics? Sales, Revenue, Price of Nuo Therapeutics? (2015 and 2016)

5.9 Ocata Therapeutics?

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Ocata Therapeutics? Product Type and Technology

5.9.2.1 POC

5.9.2.2 Tissue diagnostic

5.9.3 Ocata Therapeutics? Sales, Revenue, Price of Ocata Therapeutics? (2015 and 2016)

5.10 Opexa Therapeutics?

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Opexa Therapeutics? Product Type and Technology

5.10.2.1 POC

5.10.2.2 Tissue diagnostic

5.10.3 Opexa Therapeutics? Sales, Revenue, Price of Opexa Therapeutics? (2015 and 2016)

5.11 Osiris Therapeutics?

5.12 Teva Pharmaceuticals?

5.13 United Therapeutics

6 Stem Cell Cord Blood Technology and Development Trend

6.1 Stem Cell Cord Blood Technology Analysis

6.2 Stem Cell Cord Blood Technology Development Trend

7 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Stem Cell Cord Blood

Table Classification of Stem Cell Cord Blood

Figure USA Sales Market Share of Stem Cell Cord Blood by Type in 2015

Figure POC Picture

Figure Tissue diagnostic Picture

Figure Clinical microbiology Picture

Figure Immunodiagnostics Picture

Figure Molecular diagnostics Picture

Figure Hematology Picture

Table Applications of Stem Cell Cord Blood

Figure USA Sales Market Share of Stem Cell Cord Blood by Application in 2015

Table USA Stem Cell Cord Blood Sales, Revenue and Price (2011-2021)

Figure USA Stem Cell Cord Blood Sales and Growth Rate (2011-2021)

Figure USA Stem Cell Cord Blood Revenue and Growth Rate (2011-2021)

Table USA AAA Sales of Key Manufacturers (2015 and 2016)

Table USA AAA Sales Share by Manufacturers (2015 and 2016)

Figure 2015 AAA Sales Share by Manufacturers

Figure 2016 AAA Sales Share by Manufacturers

Table USA AAA Revenue by Manufacturers (2015 and 2016)

Table USA AAA Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA AAA Revenue Share by Manufacturers

Table 2016 USA AAA Revenue Share by Manufacturers

Table USA AAA Sales and Market Share by Type (2011-2021)

Table USA AAA Sales Share by Type (2011-2021)

Figure Sales Market Share of AAA by Type (2011-2021)

Figure USA AAA Sales Growth Rate by Type (2011-2021)

Table USA AAA Revenue and Market Share by Type (2011-2021)

Table USA AAA Revenue Share by Type (2011-2021)

Figure Revenue Market Share of AAA by Type (2011-2021)

Figure USA AAA Revenue Growth Rate by Type (2011-2021)

Table USA AAA Sales and Market Share by Application (2011-2021)

Table USA AAA Sales Share by Application (2011-2021)

Figure Sales Market Share of AAA by Application (2011-2021)

Figure USA AAA Sales Growth Rate by Application (2011-2021)

Table Caladrius Biosciences? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Caladrius Biosciences? (2015 and 2016)

Table Celgene? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Celgene? (2015 and 2016)

Table Mesoblast? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Mesoblast? (2015 and 2016)

Table Pluristem Therapeutics Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Pluristem Therapeutics (2015 and 2016)

Table Athersys Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Athersys (2015 and 2016)

Table CHA Bio & Diostech? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of CHA Bio & Diostech? (2015 and 2016)

Table Cytori Therapeutics Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Cytori Therapeutics (2015 and 2016)

Table Nuo Therapeutics? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Nuo Therapeutics? (2015 and 2016)

Table Ocata Therapeutics? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Ocata Therapeutics? (2015 and 2016)

Table Opexa Therapeutics? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Opexa Therapeutics? (2015 and 2016)

Table Osiris Therapeutics? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Osiris Therapeutics? (2015 and 2016)

Table Teva Pharmaceuticals? Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of Teva Pharmaceuticals? (2015 and 2016)

Table United Therapeutics Basic Information List

Table Stem Cell Cord Blood Sales, Revenue, Price of United Therapeutics (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370